However, the active development of the microfluidic BBB systems in recent years demonstrates the potential of these models for a variety of research tasks (Adriani et al., 2017
Though, you may need to return eventually for another dose
2G CarnoSyn Beta-Alanine thc y gia tng sc mnh c bp, sc mnh, sc chu ng v pht trin c bp tt hn
Trial-Reported Endpoints by Phase Trial Lancet 2021 Phase 2 Duration 26 weeks Population Overweight/obese, no T2D (n=706) Mean Weight Loss 10.8% at 4.5 mg vs 3.0% placebo Trial Lancet 2023 Phase 2 Duration 32 weeks Population T2D + obesity (n=92) Mean Weight Loss 8.1% cagrilintide alone
Mechanistic Interests Matrix signaling, growth-factor pathway modulation, inflammatory signaling, nitric oxide pathway interactions
This offering is strictly for research use only and is not intended for any clinical or diagnostic applications